BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21618615)

  • 1. Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.
    Jozwiak K; Plazinska A; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
    Chirality; 2011; 23 Suppl 1(Suppl 1):E1-6. PubMed ID: 21618615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.
    Jozwiak K; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
    Biochem Pharmacol; 2010 Jun; 79(11):1610-5. PubMed ID: 20144591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.
    Toll L; Pajak K; Plazinska A; Jozwiak K; Jimenez L; Kozocas JA; Tanga MJ; Bupp JE; Wainer IW
    Mol Pharmacol; 2012 Jun; 81(6):846-54. PubMed ID: 22434858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
    Plazinska A; Kolinski M; Wainer IW; Jozwiak K
    J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.
    Woo AY; Wang TB; Zeng X; Zhu W; Abernethy DR; Wainer IW; Xiao RP
    Mol Pharmacol; 2009 Jan; 75(1):158-65. PubMed ID: 18838481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective binding of agonists to the β
    Plazinska A; Plazinski W
    Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
    Plazinska A; Plazinski W; Jozwiak K
    J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
    Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
    J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
    Reinartz MT; Kälble S; Wainer IW; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
    Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
    J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.
    Beigi F; Bertucci C; Zhu W; Chakir K; Wainer IW; Xiao RP; Abernethy DR
    Chirality; 2006 Nov; 18(10):822-7. PubMed ID: 16917835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.
    Reinartz MT; Kälble S; Littmann T; Ozawa T; Dove S; Kaever V; Wainer IW; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):51-65. PubMed ID: 25342094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
    Latek D; Kolinski M; Ghoshdastider U; Debinski A; Bombolewski R; Plazinska A; Jozwiak K; Filipek S
    J Mol Model; 2011 Sep; 17(9):2353-66. PubMed ID: 21365223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.
    Plazinska A; Pajak K; Rutkowska E; Jimenez L; Kozocas J; Koolpe G; Tanga M; Toll L; Wainer IW; Jozwiak K
    Bioorg Med Chem; 2014 Jan; 22(1):234-46. PubMed ID: 24326276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor.
    Woo AY; Jozwiak K; Toll L; Tanga MJ; Kozocas JA; Jimenez L; Huang Y; Song Y; Plazinska A; Pajak K; Paul RK; Bernier M; Wainer IW; Xiao RP
    J Biol Chem; 2014 Jul; 289(28):19351-63. PubMed ID: 24831005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
    Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
    Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
    Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
    Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical and conformational study on fenoterol by ECD spectroscopy and TD-DFT calculations.
    Tedesco D; Zanasi R; Wainer IW; Bertucci C
    J Pharm Biomed Anal; 2014 Mar; 91():92-6. PubMed ID: 24441217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
    Wnorowski A; Sadowska M; Paul RK; Singh NS; Boguszewska-Czubara A; Jimenez L; Abdelmohsen K; Toll L; Jozwiak K; Bernier M; Wainer IW
    Cell Signal; 2015 May; 27(5):997-1007. PubMed ID: 25703025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.